Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Clinical & Translational Immunology|November 5, 2025
Elevated high-density lipoprotein levels following acute graft-versus-host disease onset: a potential link to T-cell dysfunction and increased relapse riskRomy Böttcher-Loschinski, Franziska Karl, Diana Drettwan, et al.
Transplantation and Cellular Therapy|March 9, 2024
Increased PD-1 Expression on Circulating T Cells Correlates with Inferior Outcome after Autologous Stem Cell TransplantationSilja Richter, Martin Böttcher, Andrej Stoll, et al.
Frontiers in Oncology|June 7, 2023
Case Report: IBD-like colitis following CAR T cell therapy for diffuse large B cell lymphomaSebastian Zundler, Francesco Vitali, Soraya Kharboutli, et al.
International Journal of Molecular Sciences|February 26, 2022
Natural NADH and FAD Autofluorescence as Label-Free Biomarkers for Discriminating Subtypes and Functional States of Immune CellsSarah Lemire, Oana-Maria Thoma, Lucas Kreiss, et al.
Stem Cells (Dayton, Ohio)|April 5, 2013
Alterations in the cellular immune compartment of patients treated with third-party mesenchymal stromal cells following allogeneic hematopoietic stem cell transplantationRegina Jitschin, Dimitrios Mougiakakos, Lena Von Bahr, et al.
Frontiers in Immunology|May 21, 2019
Human Double-Negative Regulatory T-Cells Induce a Metabolic and Functional Switch in Effector T-Cells by Suppressing mTOR ActivityTabea Haug, Michael Aigner, Moritz M Peuser, et al.
Frontiers in Immunology|October 30, 2020
The Oncometabolite 5'-Deoxy-5'-Methylthioadenosine Blocks Multiple Signaling Pathways of NK Cell ActivationBenedikt Jacobs, Sebastian Schlögl, Carolin Dorothea Strobl, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 19, 2023
CD19 Chimeric Antigen Receptor T Cell Treatment: Unraveling the Role of B Cells in Systemic Lupus ErythematosusJule Taubmann, Fabian Müller, Melek Yalcin Mutlu, et al.
Blood Advances|April 7, 2022
Bone marrow stroma cells promote induction of a chemoresistant and prognostic unfavorable S100A8/A9high AML cell subsetMartin Böttcher, Konstantinos Panagiotidis, Heiko Bruns, et al.
Journal for Immunotherapy of Cancer|November 7, 2018
CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cellsRegina Jitschin, Domenica Saul, Martina Braun, et al.
Pageof 7